UPDATE 1-FDA staff says Acadia's drug for Parkinson's disease psychosis is effective
March 25 (Reuters) - U.S. Food and Drug Administration staff members said on Friday Acadia Pharmaceuticals Inc's drug to treat psychosis associated with Parkinson's disease was an effective treatment for the condition.
No comments:
Post a Comment